Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity.
Ralf
R
Dürrwald
Andi
A
Krumbholz
Sigrid
S
Baumgarte
Michael
M
Schlegel
Thomas W
TW
Vahlenkamp
Hans-Joachim
HJ
Selbitz
Peter
P
Wutzler
Roland
R
Zell
D000180:Acrylic Resins; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology*; D000918:Antibody Specificity; D004196:Disease Outbreaks; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D057221:Influenza A Virus, H1N2 Subtype / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000276:immunology* / Q000627:therapeutic use; D008899:Mineral Oil; D009500:Neutralization Tests; D009976:Orthomyxoviridae Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D013552:Swine; D016896:Treatment Outcome
D000180:Acrylic Resins; D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D007252:Influenza Vaccines; C479038:carbomer; D008899:Mineral Oil